Chemical makers express relief after concerns over competitiveness put a stop to the EU’s overhaul of its flagship chemical ...
Indian generic medicines giant Sun Pharmaceutical Industries is buying the women’s health company Organon in a deal worth $11 ...
Attacks on fuel facilities, military bases, and industrial sites release pollutants that might harm long after the war is ...
A repurposed reagent can stereoselectively insert nitrogen into C–H bonds, even those unactivated by nearby functional groups ...
Today’s challenges only reinforce Barry Commoner’s call at a 1973 ACS regional meeting to redesign the sector “to accord with ...
The justices’ questions reflected the blurred political lines around pesticides and the EPA’s power to regulate them ...
Meanwhile, peroxisome proliferation-activated receptors (PPARs) are obesity drug targets in their own right: activating them can reduce inflammation and restore insulin sensitivity. But molecules that ...
Astellas Pharma chief R&D officer Tadaaki Taniguchi at the Astellas Life Sciences Center in Cambridge, Massachusetts. Credit: ...
Pharmaceutical giants AstraZeneca and Amgen are working with the FDA on “real-time clinical trials,” in which data are sent ...
The professor is being recognized for his fundamental advances in metal-catalyzed coupling reactions ...
The tiny particles are effectively invisible to most instruments but may play a role in stratospheric chemistry ...
Two-dimensional maps of clinopyroxene crystals that passed through a volcano’s magma chamber display a sharp increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results